{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:01:16Z","timestamp":1791666076720,"version":"4.3.4"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The gut\u2013brain axis (GBA) represents a complex, bidirectional communication network that connects the central nervous system (CNS) and the gastrointestinal system. Our study aimed to explore the correlation between the intestinal microbiota and demyelinating diseases from a bibliometric perspective, focusing on research since 2014.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A comprehensive search was carried out on the Web of Science Core Collection (WoSCC) to locate studies on the intestinal microbiota and demyelinating diseases, with a focus on publications from 1 January 2014 to 29 March 2024. We visualized and analyzed the data using VOSviewer, CiteSpace, and Charticulator.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We gathered 429 scholarly articles on the intestinal microbiota and demyelinating disorders published in the past 10\u202fyears. Research concerning the intestinal microbiota and demyelinating diseases has demonstrated a consistent increase in frequency over time. The USA has the highest number of publications, while Canada has the highest average number of citations, reaching as high as 3,429, which is greater than that of the USA. Moreover, the journal with the highest number of publications was Frontiers in Immunology, with 33 publications and 1,494 citations. The majority of the scholars focused on \u201cmultiple sclerosis\u201d and \u201cgut microbiota,\u201d which are the primary keywords in the field of the intestinal microbiota and demyelinating diseases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study conducted a comprehensive analysis of existing research investigating the correlation between the intestinal microbiota and demyelinating diseases. Using advanced bibliometric tools such as VOSviewer and CiteSpace, this study analyzed the intricate relationship between the intestinal microbiota and the pathogenesis of demyelinating conditions. In addition, the study used literature statistical analysis to identify research hotspots and future directions in the field.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnins.2025.1506566","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T07:09:30Z","timestamp":1741158570000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Bibliometric analysis of the intestinal microbiota and demyelinating diseases, particularly multiple sclerosis, since 2014"],"prefix":"10.3389","volume":"19","author":[{"given":"Ling","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le-Le","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Yin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zu-Cai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/nu15040942","article-title":"Gut-microbiota, and multiple sclerosis: background, evidence, and perspectives","volume":"15","author":"Altieri","year":"2023","journal-title":"Nutrients"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/nu13082795","article-title":"Effect of diet and dietary components on the composition of the gut microbiota","volume":"13","author":"Beam","year":"2021","journal-title":"Nutrients"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature10554","article-title":"Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination","volume":"479","author":"Berer","year":"2011","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/ijms24054596","article-title":"Demyelinating diseases: from molecular mechanisms to therapeutic strategies","volume":"24","author":"Bernardo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.atherosclerosis.2018.04.015","article-title":"Metabolic products of the intestinal microbiome and extremes of atherosclerosis","volume":"273","author":"Bogiatzi","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fnins.2018.00049","article-title":"The Vagus nerve at the Interface of the microbiota-gut-brain Axis","volume":"12","author":"Bonaz","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11154-019-09518-8","article-title":"Keto microbiota: a powerful contributor to host disease recovery","volume":"20","author":"Cabrera-Mulero","year":"2019","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.3748\/wjg.v24.i37.4217","article-title":"Focus on the gut-brain axis: multiple sclerosis, the intestinal barrier and the microbiome","volume":"24","author":"Camara-Lemarroy","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/nu13062099","article-title":"Regulation of neurotransmitters by the gut microbiota and effects on cognition in neurological disorders","volume":"13","author":"Chen","year":"2021","journal-title":"Nutrients"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"827865","DOI":"10.3389\/fimmu.2022.827865","article-title":"Gut microbiome and bile acid metabolism induced the activation of CXCR5+ CD4+ T follicular helper cells to participate in Neuromyelitis Optica Spectrum disorder recurrence","volume":"13","author":"Cheng","year":"2022","journal-title":"Front. Immunol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.3390\/cells11071239","article-title":"The influence of gut Dysbiosis in the pathogenesis and Management of Ischemic Stroke","volume":"11","author":"Chidambaram","year":"2022","journal-title":"Cells"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.cell.2012.01.035","article-title":"The impact of the gut microbiota on human health: an integrative view","volume":"148","author":"Clemente","year":"2012","journal-title":"Cell"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41582-022-00697-8","article-title":"The role of the gut microbiota in multiple sclerosis","volume":"18","author":"Correale","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","article-title":"The microbiota-gut-brain Axis","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol. Rev."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/s1474-4422(19)30356-4","article-title":"The gut microbiome in neurological disorders","volume":"19","author":"Cryan","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3390\/nu16030412","article-title":"The role of diet and gut microbiota in Alzheimer's disease","volume":"16","author":"Dissanayaka","year":"2024","journal-title":"Nutrients"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"5314541","DOI":"10.1155\/2016\/5314541","article-title":"Th17 cells pathways in multiple sclerosis and Neuromyelitis Optica Spectrum disorders: pathophysiological and therapeutic implications","volume":"2016","author":"Dos Passos","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/ana.21652","article-title":"T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta","volume":"65","author":"Durelli","year":"2009","journal-title":"Ann. Neurol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/nu14235003","article-title":"The role of ketogenic diet in the treatment of neurological diseases","volume":"14","author":"Dy\u0144ka","year":"2022","journal-title":"Nutrients"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3389\/fmicb.2019.00740","article-title":"Dietary modulation of intestinal microbiota: future opportunities in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"10","author":"Fan","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref250","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2024.105990","article-title":"Vagus nerve stimulation and gut microbiota interactions: a novel therapeutic avenue for neuropsychiatric disorders","author":"Faraji","year":"2025","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41573-019-0041-4","article-title":"Next-generation regulatory T cell therapy","volume":"18","author":"Ferreira","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s00213-018-5161-8","article-title":"Gut microbiome and brain functional connectivity in infants-a preliminary study focusing on the amygdala","volume":"236","author":"Gao","year":"2019","journal-title":"Psychopharmacology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e00362","DOI":"10.1002\/brb3.362","article-title":"An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis","volume":"5","author":"Garg","year":"2015","journal-title":"Brain Behav."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1172\/JCI143774","article-title":"Targeting the gut to treat multiple sclerosis","volume":"131","author":"Ghezzi","year":"2021","journal-title":"J. Clin. Invest."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/biomedicines10020436","article-title":"Role of microbiota-gut-brain Axis in regulating dopaminergic signaling","volume":"10","author":"Hamamah","year":"2022","journal-title":"Biomedicines"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1365-2567.2008.02837.x","article-title":"T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis","volume":"125","author":"Hedegaard","year":"2008","journal-title":"Immunology"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e12684","DOI":"10.1111\/jne.12684","article-title":"The role of the gut microbiota in development, function and disorders of the central nervous system and the enteric nervous system","volume":"31","author":"Heiss","year":"2019","journal-title":"J. Neuroendocrinol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1016\/j.cell.2022.08.021","article-title":"Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course","volume":"185","year":"2022","journal-title":"Cell"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2119\/molmed.2011.00311","article-title":"Influence of dietary components on regulatory T cells","volume":"18","author":"Issazadeh-Navikas","year":"2012","journal-title":"Mol. Med."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"5821","DOI":"10.1038\/s41598-019-42183-0","article-title":"Long-term benefit of microbiota transfer therapy on autism symptoms and gut microbiota","volume":"9","author":"Kang","year":"2019","journal-title":"Sci. Rep."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat. Med."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"6000","DOI":"10.1038\/s41467-021-26209-8","article-title":"High-coverage metabolomics uncovers microbiota-driven biochemical landscape of interorgan transport and gut-brain communication in mice","volume":"12","author":"Lai","year":"2021","journal-title":"Nat. Commun."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1212\/NXI.0000000000200118","article-title":"Effect of Ocrelizumab on B- and T-cell receptor repertoire diversity in patients with relapsing multiple sclerosis from the randomized phase III OPERA trial","volume":"10","author":"Laurent","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflam."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1073\/pnas.1000082107","article-title":"Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis","volume":"108","author":"Lee","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1093\/advances\/nmac065","article-title":"Role of ketogenic diets in multiple sclerosis and related animal models: an updated review","volume":"13","author":"Lin","year":"2022","journal-title":"Adv. Nutr."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"pyw020","DOI":"10.1093\/ijnp\/pyw020","article-title":"Growing up in a bubble: using germ-free animals to assess the influence of the gut microbiota on brain and behavior","volume":"19","author":"Luczynski","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1177\/135245859900500206","article-title":"Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis","volume":"5","author":"Matusevicius","year":"1999","journal-title":"Multiple Sclerosis"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S1474-4422(15)70015-3","article-title":"The systematic search for risk factors in multiple sclerosis. The lancet","volume":"14","author":"McKay","year":"2015","journal-title":"Neurology"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1212\/WNL.0b013e3181ebdd64","article-title":"Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis","volume":"75","author":"Mehling","year":"2010","journal-title":"Neurology"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"102647","DOI":"10.1016\/j.autrev.2020.102647","article-title":"The role of TH17 cells in multiple sclerosis: therapeutic implications","volume":"19","author":"Moser","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.cell.2018.04.027","article-title":"The gut microbiota mediates the anti-seizure effects of the ketogenic diet","volume":"173","author":"Olson","year":"2018","journal-title":"Cell"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"718220","DOI":"10.3389\/fimmu.2021.718220","article-title":"The gut-brain Axis in multiple sclerosis. Is its dysfunction a pathological trigger or a consequence of the disease?","volume":"12","author":"Parodi","year":"2021","journal-title":"Front. Immunol."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/biom12030433","article-title":"Multiple sclerosis and microbiome","volume":"12","author":"Preiningerova","year":"2022","journal-title":"Biomol. Ther."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1126\/sciimmunol.abc7191","article-title":"Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis","volume":"5","author":"Pr\u00f6bstel","year":"2020","journal-title":"Sci. Immunol."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41590-022-01387-9","article-title":"TH17 cell heterogeneity and its role in tissue inflammation","volume":"24","author":"Schnell","year":"2023","journal-title":"Nat. Immunol."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1080\/17512433.2019.1612744","article-title":"Play in advance against neurodegeneration: exploring enteric glial cells in gut-brain axis during neurodegenerative diseases","volume":"12","author":"Seguella","year":"2019","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e0033820","DOI":"10.1128\/cmr.00338-20","article-title":"A comprehensive review on the role of the gut microbiome in human neurological disorders","volume":"35","author":"Shokufeh Ghasemian","year":"2022","journal-title":"Clin. Microbiol. Rev."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.expneurol.2014.03.009","article-title":"Th17 cells in central nervous system autoimmunity","volume":"262","author":"Sie","year":"2014","journal-title":"Exp. Neurol."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"105840","DOI":"10.1016\/j.phrs.2021.105840","article-title":"The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders","volume":"172","author":"Soca\u0142a","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s12035-018-1188-4","article-title":"The gut microbiome alterations and inflammation-driven pathogenesis of Alzheimer's disease-a critical review","volume":"56","author":"Sochocka","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/ni0901-762","article-title":"Multiple sclerosis: a two-stage disease","volume":"2","author":"Steinman","year":"2001","journal-title":"Nat. Immunol."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-022-01148-1","article-title":"The gut microbiota in multiple sclerosis varies with disease activity","volume":"15","author":"Thirion","year":"2023","journal-title":"Genome Med."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/ana.24901","article-title":"The gut microbiome in human neurological disease: a review","volume":"81","author":"Tremlett","year":"2017","journal-title":"Ann. Neurol."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1177\/1352458517737369","article-title":"Gut microbiome and pediatric multiple sclerosis","volume":"24","author":"Tremlett","year":"2018","journal-title":"Multiple Sclerosis"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1038\/s41598-022-07336-8","article-title":"B-cell-depletion reverses dysbiosis of the microbiome in multiple sclerosis patients","volume":"12","author":"Troci","year":"2022","journal-title":"Sci. Rep."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1225875","DOI":"10.3389\/fnins.2023.1225875","article-title":"The gut microbiota-brain axis in neurological disorder","volume":"17","author":"Ullah","year":"2023","journal-title":"Front. Neurosci."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12967-016-1058-7","article-title":"Microbiota and neurologic diseases: potential effects of probiotics","volume":"14","author":"Umbrello","year":"2016","journal-title":"J. Transl. Med."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.2147\/NDT.S378372","article-title":"Knowledge atlas of the co-occurrence of epilepsy and autism: a bibliometric analysis and visualization using VOSviewer and CiteSpace","volume":"18","author":"Wang","year":"2022","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2013.12.015","article-title":"The role of microbiome in central nervous system disorders","volume":"38","author":"Wang","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.2174\/1570159X19666210629145351","article-title":"Role of gut microbiota in multiple sclerosis and potential therapeutic implications","volume":"20","author":"Wang","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1157358","DOI":"10.3389\/fneur.2023.1157358","article-title":"Epilepsy, gut microbiota, and circadian rhythm","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Neurol."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.3390\/foods13121853","article-title":"Effect of bioactive peptides on gut microbiota and their relations to human health","volume":"13","author":"Wijesekara","year":"2024","journal-title":"Food Secur."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11657-021-00929-2","article-title":"Worldwide research tendency and hotspots on hip fracture: a 20-year bibliometric analysis","volume":"16","author":"Wu","year":"2021","journal-title":"Arch. Osteoporos."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"e0260384","DOI":"10.1371\/journal.pone.0260384","article-title":"Bacterial variation in the oral microbiota in multiple sclerosis patients","volume":"16","author":"Zangeneh","year":"2021","journal-title":"PLoS One"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.it.2011.02.007","article-title":"IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease","volume":"32","author":"Zepp","year":"2011","journal-title":"Trends Immunol."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s40168-021-01107-9","article-title":"Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis","volume":"9","author":"Zhao","year":"2021","journal-title":"Microbiome"}],"updated-by":[{"DOI":"10.3389\/fnins.2025.1635017","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000}}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1506566\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T09:10:29Z","timestamp":1749546629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1506566\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":67,"alternative-id":["10.3389\/fnins.2025.1506566"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2025.1506566","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fnins.2025.1635017","asserted-by":"object"}]},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"article-number":"1506566"}}